Studies Find New Cancer Risks Associated With Textured Breast Implants
Two new studies have discovered new cancer risks associated with textured breast implants.
A case study published on October 7 involved a woman diagnosed with breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) two years after removal of textured breast implants, and a report published on October 13 found that textured breast implants might increase breast cancer risk in women who receive implants following mastectomies.
BIA-ALCL Found In Woman Two Years After Textured Breast Implant Removal
Researchers in Poland presented a case of a 46-year-old woman who was “one of the first described cases of” BIA-ALCL in Poland.
“Especially interesting is the fact that the lymphoma developed two years after the removal of the implants, and the pathology occurred in the axillary lymph nodes,” the researchers stated.
The researchers found that the age range of females they analyzed with BIA-ALCL diagnoses is between 27 and 87 years and that “the use of textured implants seems to be one of the most important risk factors of novel lymphoma.”
The researchers concluded that breast implant patients should be told about the risk of BIA-ALCL and its symptoms, noting that information and knowledge about the disease remain limited and acknowledging a “need to broaden knowledge” about BIA-ALCL.
BIA-ALCL is an immune system cancer. Many lawsuits claim it is caused by textured breast implants. Many lawsuits involve Allergan’s recalled Biocell textured implants.
Textured Breast Implants May Increase Breast Cancer Relapse Risk
South Korean researchers found “a statistically significant association” between the use of textured breast implants versus smooth breast implants and “decreased disease-free survival regardless of tumor stage and estrogen receptor status.”
The researchers state this suggests an association between using textured breast implants for reconstruction after mastectomies and a higher risk of breast cancer relapse, “warranting the need for further investigation.”
The cohort study involved 650 patients with a mean age of 43.5 years, representing 687 cases. 274 of the cases received a smooth implant and 413 received a textured implant. The study was conducted at Samsung Medical Center in Seoul, South Korea from January 1, 2011 to December 31, 2016.
The study found that those who received textured breast implant faced 3.054 times the risk of not surviving disease-free.
The association of textured implant use with cancer recurrence was more prominent in cases involving late-stage (II or III) tumors.